Metabolism - Clinical and Experimental
Volume 52, Issue 3 , Pages 338-343 , March 2003

The lipoprotein lipase gene HindIII polymorphism is associated with lipid levels in early-onset type 2 diabetic patients

Received 1 June 2002 ,Accepted 16 September 2002.

References 

  1. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicromemia syndrome. In:  Scriver CR,  Beaudet AL,  Sly WS, et al. editor. The Molecular Basis of Inherited Disease. New York, NY: McGraw-Hill; 1989;p. 1165–1180
  2. Okubo M, Murase T. Hypertriglyceridemia and low HDL cholesterol in Japanese patients with NIDDM. Diabetes. 1996;45(suppl 3):S123–S125
  3. Knudsen P, Eriksson J, Lahdenpera S, et al.  Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group Diabetologia. 1995;38:344–350
  4. Frenais R, Nazih H, Ouguerram K, et al.  In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: A kinetic study in control subjects and patients with type II diabetes mellitus. J Clin Endocrinol Metab. 2001;86:1962–1967
  5. Perusse L, Rice T, Despres JP, et al.  Familial resemblance of plasma lipids, lipoproteins and postheparin lipoprotein and hepatic lipases in the HERITAGE Family Study. Arterioscler Thromb Vasc Biol. 1997;17:3263–3269
  6. Gotoda T, Yamada N, Murase T, et al.  Detection of three separate DNA polymorphisms in the human lipoprotein lipase gene by gene amplification and restriction endonuclease digestion. J Lipid Res. 1992;33:1067–1072
  7. Peacock RE, Hamsten A, Nilsson-Ehle P, et al.  Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis. 1992;97:171–185
  8. Ahn YI, Kamboh MI, Hamman RF, et al.  Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res. 1993;34:421–428
  9. Ye P, Pei L, Wang S. Polymorphisms of the human lipoprotein lipase gene: Possible association with lipid levels in patients with coronary heart disease in Beijing area. Chin Med Sci J. 1996;11:157–161
  10. Jemaa R, Fumeron F, Poirier O, et al.  Lipoprotein lipase gene polymorphisms: Associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Temoin sur l'Infarctus du Myocarde. J Lipid Res. 1995;36:2141–2146
  11. Mattu RK, Needham EW, Morgan R, et al.  DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb. 1994;14:1090–1097
  12. Thorn JA, Chamberlain JC, Alcolado JC, et al.  Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis. 1990;85:55–60
  13. Larson I, Hoffmann MM, Ordovas JM, et al.  The lipoprotein lipase HindIII polymorphism: Association with total cholesterol and LDL-cholesterol, but not with HDL and triglycerides in 342 females. Clin Chem. 1999;45:963–968
  14. Jemaa R, Tuzet S, Betoulle D, et al.  Hind III polymorphism of the lipoprotein lipase gene and plasma lipid response to low calorie diet. Int J Obes Rel Metab Disord. 1997;21:280–283
  15. Gerdes C, Gerdes LU, Hansen PS, et al.  Polymorphisms in the lipoprotein lipase gene and their associations with plasma lipid concentrations in 40-year-old Danish men. Circulation. 1995;92:1765–1769
  16. Wang XL, McCredie RM, Wilcken DE. Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. Circulation. 1996;93:1339–1345
  17. Ukkola O, Savolainen MJ, Salmela PI, et al.  DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus. Atherosclerosis. 1995;115:99–105
  18. Gambino R, Scaglione L, Alemanno N, et al.  Human lipoprotein lipase HindIII polymorphism in young patients with myocardial infarction. Metabolism. 1999;48:1157–1161
  19. Reaven GM, Grenfield S. Diabetic hypertriglyceridaemia: Evidence for three clinical syndromes. Diabetes. 1982;30(suppl 2):66–75
  20. Vohl MC, Lamarche B, Moorjani S, et al.  The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity. Arterioscl Thromb Vasc Biol. 1995;15:714–720
  21. Thomas GN, Tomlinson B, Chan JC, et al.  The Trp64Arg polymorphism of the beta3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord. 2000;24:545–551
  22. World Health Organization . Diabetes Mellitus: A Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; 1985;
  23. World Health Organization . The Asia-Pacific Perspective: Redefining Obesity and its Treatment. In: WHO, Western Pacific Region, IASO International Association for the Study of Obesity: Health Communications Australia Pty Limited; 2000;p. 18
  24. Bruin T, Reymer PW, Groenemeyer BE, et al.  HindIII-polymorphism in the LPL-gene detected by PCR. Nucleic Acids Res. 1991;19:6346
  25. Chamberlain JC, Thorn JA, Oka K, et al.  DNA polymorphisms at the lipoprotein lipase gene: Associations in normal and hypertriglyceridaemic subjects. Atherosclerosis. 1989;79:85–91
  26. Peinado-Onsurbe J, Staels B, Deeb S, et al.  Lipoprotein lipase expression in undifferentiated hepatoma cells is regulated by progesterone and protein kinase A. Biochemistry. 1992;31:10121–10128
  27. Pradines-Figueres A, Barcellini-Couget S, Dani C, et al.  Inhibition by serum components of the expression of lipoprotein lipase gene upon stimulation by growth hormone. Biochem Biophys Res Commun. 1990;166:1118–1125
  28. Breier C, Muhlberger V, Drexel H, et al.  Essential role of post-heparin lipoprotein lipase activity and of plasma testosterone in coronary artery disease. Lancet. 1985;1:1242–1244
  29. Iverius PH, Brunzell JD. Relationship between lipoprotein lipase activity and plasma sex steroid level in obese women. J Clin Invest. 1988;82:1106–1112
  30. Bagdade JD, Porte D, Bierman EL. Diabetic lipemia. A form of acquired fat-induced lipemia. N Engl J Med. 1967;276:427–433
  31. Pollare T, Vessby B, Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thromb. 1991;11:1192–1203
  32. Zhang Q, Liu Y, Liu BW, et al.  Common genetic variants of lipoprotein lipase and apolipoproteins AI-CIII that relate to coronary artery disease: A study in Chinese and European subjects. Mol Genet Metab. 1998;64:177–183
  33. Georges JL, Regis-Bailly A, Salah D, et al.  Family study of lipoprotein lipase gene polymorphisms and plasma triglyceride levels. Genet Epidemiol. 1996;13:179–192
  34. Ahn YI, Ferrell RE, Hamman RF, et al.  Association of lipoprotein lipase gene variation with the physiological components of the insulin-resistance syndrome in the population of the San Luis Valley, Colorado. Diabetes Care. 1993;16:1502–1506
  35. Cole SA, Aston CE, Hamman RF, et al.  Association of a PvuII RFLP at the lipoprotein lipase locus with fasting insulin levels in Hispanic men. Genet Epidemiol. 1993;10:177–188
  36. Eckel RH. Adipose tissue lipoprotein lipase. In:  Borensztajn J editors. Lipoprotein Lipase. Chicago, IL: Evener; 1987;p. 79–132
  37. Eckel RH, Yost TJ. Weight reduction increases adipose tissue lipoprotein lipase responsiveness in obese women. J Clin Invest. 1987;80:992–997
  38. Heizmann C, Kirchgessner T, Kwiterovich PO, et al.  DNA polymorphism haplotypes of the human lipoprotein lipase gene: Possible association with high density lipoprotein levels. Hum Genet. 1991;86:578–584

☆ Supported by a Direct Grant for Research (code no. 2040526) from the Medicine Panel, The Chinese University of Hong Kong and grants from Hong Kong Research Grants Council (no. CUHK 4095/00M and CUHK Strategic Research Program 9902).

☆☆ Address reprint requests to Dr G. Neil Thomas, Department of Community Medicine, 5/F Academic and Administration Block, Faculty of Medicine Building, University of Hong Kong, 21 Sassoon Rd, Hong Kong.

PII: S0026-0495(02)05269-1

doi: 10.1053/meta.2003.50053

Metabolism - Clinical and Experimental
Volume 52, Issue 3 , Pages 338-343 , March 2003

Article Tools